Dermapharm Holding SE
XMUN:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
|
L
|
Linde PLC
F:LIN
|
UK |
|
I
|
Inspire Medical Systems Inc
F:2DR
|
US |
|
Anheuser Busch Inbev SA
F:1NBA
|
BE |
|
F
|
Ford Motor Co
DUS:FMC1
|
US |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
Grupo Aeroportuario del Centro Norte SAB de CV
NASDAQ:OMAB
|
MX |
|
I
|
InterDigital Inc
F:IDI
|
US |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 53.48 EUR with a low forecast of 46.6 EUR and a high forecast of 66.06 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
53.48
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 53.48 EUR with a low forecast of 46.6 EUR and a high forecast of 66.06 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
9%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 9%.
